Equity
-€37,388
Debts exceed assets in financial year 2025.
ColdFever
Overview
Lifetime
2 annual accounts with figures on one time axispeak -€15,194 (2024)
-€17,856▼ €2,662
lowest -€26,550 (2024)
-€25,838▲ €712
peak -€11,550 (2024)
-€37,388▼ €25,838
€85,764▲ 39.3%
Board2 names since 2023
2 directorsGIELEN Bert and 1 other
Owners
Documentsfilings and deeds
27-08-202627 days late
2025micro format
Gross margin from -€15,194 to -€17,856Loss of €25,838Equity from -€11,550 to -€37,388Debts from €61,567 to €85,764
Key points
from the 2025 annual accountsLosses
-€52,388 in two years
The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.
Debts
€85,764 177% of the balance sheet
2025 accounts filed 27 days after the deadlineTurnover not published (micro format)
Checked score
35
Weak
Financially stronger than 13% of micro companies in food products (NACE 10)
Probability in this band: 4.2% to 15.0%
Bankruptcy probability within 12 months
4.8% Elevated
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 1.1% across 3,080 companies (NACE 10, micro).
About 5 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 5.4%
01-2025: 5.8%▲ +0.4 percentage points vs 12-2024
02-2025: 5.8%● unchanged vs 01-2025
03-2025: 5.7%▼ -0.1 percentage points vs 02-2025
04-2025: 5.6%▼ -0.1 percentage points vs 03-2025
05-2025: 6.0%▲ +0.4 percentage points vs 04-2025
06-2025: 6.1%▲ +0.1 percentage points vs 05-2025
07-2025: 6.2%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 6.2%● unchanged vs 07-2025highest value
09-2025: 6.2%● unchanged vs 08-2025highest value
10-2025: 4.7%▼ -1.5 percentage points vs 09-2025
11-2025: 4.7%● unchanged vs 10-2025
12-2025: 4.7%● unchanged vs 11-2025
01-2026: 4.6%▼ -0.1 percentage points vs 12-2025
02-2026: 4.6%● unchanged vs 01-2026
03-2026: 4.5%▼ -0.1 percentage points vs 02-2026lowest value
04-2026: 4.6%▲ +0.1 percentage points vs 03-2026
05-2026: 4.6%● unchanged vs 04-2026
06-2026: 4.5%▼ -0.1 percentage points vs 05-2026
07-2026: 4.8%▲ +0.3 percentage points vs 06-2026
08-2026: 5.9%▲ +1.1 percentage points vs 07-2026
09-2026: 4.8%▼ -1.1 percentage points vs 08-2026
10-2026: 4.8%● unchanged vs 09-2026
11-2026: 4.8%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Sector: Manufacture of food products (NACE 10)
Founded in 2023
Negative equity -€37,388
lowers risk
Liquidity: current ratio 0.37, cash €16,427
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 10, micro). It does better than 6% of them on solvency, 35% on liquidity, 6% on profitability and 3% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the elevated class on 30-06-2025, 6.3% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 7,639 companies had the same profile as ColdFever has now. Each dot stands for 20 companies, two years later.
84.8%
were still trading
5.6%
stopped another way
8.8%
went bankrupt
Another 0.8% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of ColdFever itself: 4.8% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,639 companies, not a prediction for ColdFever. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is insufficient, with a current ratio of 0.37 (0.42 in 2024), below 1. Short-term debt is 177.3% and cash 34% of total assets. Equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
2425
2024 to 2025 · latest year -€37,388
raises risk · 2025 accounts filed 27 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filingsDeviation from the deadline
2025
27 days late
2024
30 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 2 accounts on average 29 days after the deadline. In the sector (NACE 10), the median for financial year 2024 was 4 days before the deadline, and 38% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- Tom Lintermans 50%score 81equity €102,713 (2025) · 2025 annual accounts of Tom Lintermans
Recent changes
New establishment in Beersel
ColdFever WH, Heideveld 12
Incorporation
Founding capital of €15,000, 100 shares · Founders: Tom Lintermans and GIELEN Bert · Appointments: Tom Lintermans (director) and GIELEN Bert (director) · published on 21-06-2023 · Gazette deed
First establishment
Korenbeekstraat 71, Molenbeek-Saint-Jean
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ColdFever Molenbeek-Saint-Jean | €48,376 | -€17,856 | -77.3% | - |
| BB-BD Anderlecht | €75,002 | -€1,240 | -2.6% | - |
| MY FATHER COFFEE Aalst | €81,331 | -€3,263 | -63.1% | - |
| Honest Trade Oud-Heverlee | €42,107 | -€200 | 40.0% | - |
| Charbonnages de Beeringen Beringen | €23,790 | €1,441 | 2.6% | - |
| NuSiaM Ixelles | €36,302 | €1,614 | -40.2% | - |
| La Vida Mocha Oud-Heverlee | €126,628 | -€23,407 | -4.9% | - |
These companies have the same main activity as ColdFever: manufacture of food products (NACE 10830). They are comparable in size and age: total assets between €23,800 and €127,000, founded between 2018 and 2024.
Official details
Source: KBO- Status
- Active since 19-06-2023Normal situation
- Activity
- Manufacture of food productsNACE 10830and 1 other
- Establishment units
- 2.346.421.1891080 Molenbeek-Saint-Jean, since 19-06-2023
- 2.366.655.0921654 Beersel, since 01-05-2024
- Financial year end
- 31 December
- Peppol
- Reachable
Annual accounts 2025
- -€17,856▼ 17.5%
- €25,838▼ 2.7%
- -€37,388▼ 224%
- €48,376▼ 3.3%
- Filing
- Filed on 27-08-2026
Insights on ColdFever
The computed 12-month bankruptcy probability of ColdFever is 4.8% (elevated). The 2025 annual accounts show negative equity (-€37,388) and a net result of -€25,838.
Its solvency ranks better than 8% of 1,916 sector peers (NACE 10, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 27-08-2026, 27 days late-€17,856
▼ €2,662
-€25,813
▲ €680
-€25,838
▲ €712
-€54,456
▼ €18,964
-77.3%
▼ 54.2 percentage points
0.37
▼ 0.06
Turnover and EBIT margin are not published. The micro format does not require them.
Balance sheet
balance sheet total €48,376 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
-77.3%
Higher than 8% of 1,916 companies in 2025.
0.37
Higher than 13% of 1,860 companies in 2025.
-53.4%
Lower than 95% of 1,876 companies in 2025.
ColdFever
Middle half of the sector
80% of the sector
Micro accounts in food products (NACE 10)
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
48,376 | 50,017 | |
21/28 |
17,068 | 23,942 | |
22/27 |
15,394 | 22,268 | |
23 |
9,349 | 13,572 | |
24 |
2,168 | 3,593 | |
26 |
3,877 | 5,104 | |
28 |
1,674 | 1,674 | |
29/58 |
31,308 | 26,074 | |
3 |
8,700 | 3,162 | |
30/36 |
8,700 | 3,162 | |
40/41 |
5,449 | 4,121 | |
40 |
4,237 | 2,512 | |
41 |
1,212 | 1,609 | |
54/58 |
16,427 | 18,434 | |
490/1 |
731 | 358 | |
| Balance sheet: equity and liabilities | |||
10/49 |
48,376 | 50,017 | |
10/15 |
-37,388 | -11,550 | |
10/11 |
15,000 | 15,000 | |
14 |
-52,388 | -26,550 | |
17/49 |
85,764 | 61,567 | |
42/48 |
85,764 | 61,567 | |
44 |
1,245 | 2,921 | |
440/4 |
1,245 | 2,921 | |
47/48 |
84,520 | 58,645 | |
| Income statement | |||
9900 |
-17,856 | -15,194 | |
630 |
6,875 | 10,314 | |
640/8 |
1,082 | 984 | |
9901 |
-25,813 | -26,492 | |
75/76B |
46 | 19 | |
75 |
46 | 19 | |
65/66B |
72 | 76 | |
65 |
72 | 76 | |
9903 |
-25,838 | -26,550 | |
9904 |
-25,838 | -26,550 | |
9905 |
-25,838 | -26,550 | |
| Appropriation of the result | |||
9906 |
-52,388 | -26,550 | |
14P |
-26,550 | - | |
| Document | |||
The notes to these accounts have 10 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 27-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank2025 annual accounts filed 27 days after the deadline. Filed on 27 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00449675.
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| -18,938 | -16,178 | ||
| -18,964 | -16,236 | ||
| 0 | 34,257 | ||
| -2,007 | - | ||
| -54,456 | -35,492 | ||
| -77.3% | -23.1% | ||
| 0.37 | 0.42 | ||
| 0.26 | 0.37 | ||
| -53.4% | -53.1% | ||
| -262.59 | -211.73 |
Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Tangible fixed assets | - | €32,583 |
| Financial fixed assets | €0 | €1,674 |
| €6,875 | €10,314 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on ColdFever
The operating result for 2025 is a loss of €25,813, smaller than the loss of €26,492 in 2024.
Equity is negative. Debt (€85,764) exceeds the balance-sheet total (€48,376).
Board & ownership
Board
2 directors, since incorporationDirector (not named in the articles)
since 16-06-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 27-08-2026
Tom Lintermans BVBA
Director (not named in the articles)
appointed by deed of 21-06-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 27-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “rechtspersoon-bestuurder zetelen in het bestuursorgaan van de vennootschap. De rechtspersoonbestuurder mag de vaste vertegenwoordiging niet…”deed of 21-06-2023
Mandates through the years
2 names, the dashed line is todayGIELEN Bert
Director (not named in the articles)
Director (not named in the articles)
Tom Lintermans
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- GIELEN Bert
- Director (not named in the articles), from 16-06-2023 to date
- Tom Lintermans
- Director (not named in the articles), appointed by deed of 21-06-2023, still in office
Control
Shareholder
Equity €102,713
Profit €10,866 in 2025 (profit €71,530 in 2024)
Checked score 81
Source: accounts Tom Lintermans 2025
50%
This company
ColdFever
Equity -€37,388
Loss €25,838 in 2025
Capital
- Contribution
- €15,000
- Shares
- 100
- Contribution per share
- €150
- Equity per share
- -€374 in 2025
- Source
- deed of 21-06-2023
Owners through the years
as the annual accounts name themOwners as a list
- Tom Lintermans
Source: lists of holdings in the owners' accounts
Articles of association
deed of 21-06-2023 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director“Algemene vergadering kan mandaat steeds beëindigen wegens wettige reden”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 19:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Benoemen of ontslaan één of meer vereffenaars, gewone meerderheid”
Capital transactions
Shareholders according to the deeds
At incorporation
deed of 21-06-2023 ↗
- GIELEN Bert 50 shares (50%) · €7,500
- Tom Lintermans (BE 0651.931.159) 50 shares (50%) · €7,500
Capital over time
- 21-06-2023 Incorporation · €15,000 · 100 shares
Network & group
No group
ColdFever has no parent and no holdings in its annual accounts.
At the same address
Korenbeekstraat 71, 1080 Molenbeek-Saint-Jean · 1 other company| Tom Lintermans
registered office since 14-04-2016 · founded in 2016 |
total assets €451,608 (2025) 0651.931.159 |
Connections & network
2 current directorsThe network starts from the directors of ColdFever. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Timeline
5 events since 2023Filings
Establishments
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 27 days late
2025
Annual accounts 2024 filed PDFmicro format · 30 days late
2024
New establishment in Beersel ColdFever WH, Heideveld 12
2023
IncorporationFounding capital of €15,000, 100 shares · Founders: Tom Lintermans and GIELEN Bert · Appointments: Tom Lintermans (director) and GIELEN Bert (director) · published on 21-06-20238 points ▸
- Board rule, 2
- Director appointment, Tom Lintermans (director (not named in the articles))
- Director appointment, GIELEN Bert (director (not named in the articles))
- Permanent representative, LINTERMANS Tom
- Founder, GIELEN Bert
- Founder, Tom Lintermans
- Founding capital, €15,000, 100 shares
- 100 shares
- The deed holds 4 more points.
First establishment Korenbeekstraat 71, Molenbeek-Saint-Jean
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
ColdFever was incorporated on 19 June 2023 as a private limited company by Tom Lintermans and one natural person, with a starting capital of €15,000.12 The board currently has 2 members.3 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Company details
Identity
- Enterprise number
- 0802.892.457
- VAT number
- BE 0802.892.457
- Peppol ID
- 0208:0802892457
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 19-06-2023
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 19:00deed of 21-06-2023 (in Dutch)
- Peppol
- Reachable via PeppolFollow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- ColdFever in Dutch
- Entity type
- Legal entity
Activities
NACEBEL 202510830
Manufacture of food products main activity
46370
Wholesale trade
Codes under NACEBEL 2008
10830
Manufacture of food products main activity
46370
Wholesale trade
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Fabriceren en het leveren van koffieproducten,thee en andere niet-alcoholische dranken; Het branden,produceren en vervaardigen van…”deed of 21-06-2023 (in Dutch)
6 activities
- Fabriceren en het leveren van koffieproducten,thee en andere niet-alcoholische dranken
- Het branden,produceren en vervaardigen van koffieproducten en thee
- Het stellen van alle handelingen met betrekking tot verkoopbemiddeling,het optreden als handelsvertegenwoordiger,handelscommissionair,handelsagent
- De participatie,onder welke vorm het ook zij,in de oprichting,ontwikkeling,omvorming en controle van ondernemingen,Belgische of buitenlandse,commerciële,financiële,industriële of andere
- Onderneming voor het beheer van eigen beleggingen en vermogens,roerend en onroerend
- Het aan- en verkopen,het huren en het verhuren,het beheren,het verbouwen van,inclusief het verwerven en verlenen van vruchtgebruik,opstalrecht,erfpacht en alle zakelijke of persoonlijke rechten m.b.t. onroerende goederen
Registered office and establishments
2 establishments| Establishment | Since | Unit number | FASFC approval |
|---|---|---|---|
| Korenbeekstraat 71 registered office 1080 Molenbeek-Saint-Jean | 19-06-2023 | 2.346.421.189 | |
| ColdFever WH Heideveld 12, 1654 Beersel | 01-05-2024 | 2.366.655.092 | Lemonade facturer Coffee roaster, tea manufacturer |
Buildings and parcels at the address
- Ground area
- 146 m²
- Buildings
- 65 m²
- Volume, LiDAR
- 663 m³
- Tallest building
- 13.4 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21526D0045/00D003 | 146 m² | 1 · 65 m² | 13.4 m · 4 |
Recognitions
Food safety, FASFC
1 siteBeerselunit number 2.366.655.092
Contact
Website
www.drinkcoldfever.com establishment in Beersel
E-mail
bert@drinkcoldfever.com establishment in Beersel
Phone
+32 456 79 68 13 establishment in Beersel